Successful therapy of hepatorenal syndrome with norepinephrine;Erfolgreiche therapie des hepatorenalen syndroms mit noradrenalin

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 12, 2000, Pages 945-950

  Pehl, C ^a   Schepp, W ^a  

^a Munich Municipal Hospital   (Germany)

Author keywords

Dopamine; Hepatorenal Syndrome; Liver Cirrhosis; Norepinephrine; Ornipressin; Peripheral Vasodilatation; Renal Vasoconstriction

Indexed keywords

ALBUMIN; CREATININE; DOPAMINE; FUROSEMIDE; NORADRENALIN; ORNIPRESSIN; SODIUM; UREA; VASOPRESSIN;

ADULT; ALCOHOL LIVER DISEASE; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; EPILEPTIC DISCHARGE; FEMALE; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MICTURITION; RECURRENT DISEASE; SODIUM EXCRETION; URINE VOLUME;

ADULT; FEMALE; HEPATITIS, ALCOHOLIC; HEPATORENAL SYNDROME; HUMANS; INTENSIVE CARE; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; NOREPINEPHRINE; TREATMENT OUTCOME;

EID: 0034508356     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-10020     Document Type: Article

References (48)

1. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure
2. Das hepatorenale syndrom
3. New clues to the pathophysiology of hepatorenal failure
4. Pathophysiology of ascites formation in cirrhosis of the liver
5. Pathogenesis of ascites and hepatorenal syndrome
6. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
7. The hepatorenal syndrome
8. Nierenfunktionsstöruogen bei lebererkrankungen
9. Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis
10. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis
11. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
12. Ornipressin in der therapie des hepatorenalen syndroms
13. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
14. Renal failure in patients with cirrhosis of the liver. Evaluation of intrarenal blood flow by para-iminohippurate extraction and response to angiotensin
15. False neurotransmitters and hepatic failure
16. Acute changes in renal execretion of water and solute in patients with Laennec's cirrhosis, induced by the administration of the pressor amine, metaramino
17. Simultaneous determination of cardiac output and renal function inpatients with Laenec's cirrhosis during the adminstration of the pressor amine metaraminol
18. Treatment of the hepatorenal syndrome with metaraminol
19. Reversal of hepatorenal syndrome with the combination of norepinephrine and dopamine
20. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
21. Erfolgreiche konservative therapie des hepatorenalen syndroms mit dem vasopressin-1-rezeproragonisr ornipressin
22. Alcoholic hepatitis: Pathogenesis and approaches to treatment
23. Comparative studies on the diuretic and biochemical effects of prednisolone and spironolacrone in hepatic cirrhosis
24. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome
25. Captopril in the hepatorenal syndrome
26. Renal haemodynamic response to captopril in decompensated cirrhosis
27. The renin angiotensin system in cirrhosis: Its relation to functional renal failure
28. Renal failure in the patient with cirrhosis. The role of active vasoconstriction
29. Acute pulmonary oedema following administration of ornithine-8-vasopressin
30. Studies of the cardio-vascular system in the hypotension of liver failure
31. Plasma norepinephrine, weak neurotransmitters and renin activity during active tilting in liver cirrhosis: Relationship with cardiovascular homeostasis and renal function
32. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal haemodynamics and renal function in cirrhotic patients with ascites
33. Sodium excretion in advanced cirrhosis: Effect of expansion of central blood volume and suppression of plasma aldosterone
34. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients
35. The kidney in liver disease
36. Angiotensin, norepinephrine, and renal transport of electrolytes and water in normal man and in cirrhosis with ascites
37. Role of vagal afferents in the control of renal sympathetic nerve activity in the rabbit
38. Vasopressor-induced natriuresis and altered intrarenal haemodynamics in cirrhotic man
39. Klinische und experimentelle untersuchungen über die Wirkung von Dopamin auf die Hämodynamik und Funktion von Niere und Leber
40. Dopamine in the hepatorenal syndrome
41. Response to dopamine hydrochloride in the hepatorenal syndrome
42. Effects of dopamine on renal function in patients with cirrhosis
43. Studies on the mechanism of sodium diuresis following dopamine
44. Dopamine-fusemide therapy in acure renal failure
45. Is renal close dopamine protective or therapeutic? Yes
46. How do loop diuretics act?
47. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat
48. Restoration of diuresis in the initial period of the oligoanuric stage of acute renal failure by dopamine-furosemide infusion